Navigation Links
Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging,Growth Opportunities Conference

MALVERN, Pa., June 28, 2007 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc. today announced that Mr. Armando Anido, Chief Executive Officer and President, and Mr. Jim Fickenscher, Chief Financial Officer, will participate in the 2007 CEUT Emerging Growth Opportunities Conference to be held July 10 through July 12, 2007 at the Mandarin Oriental Hotel in New York City. Mr. Anido is scheduled to present an overview of the Company and its product pipeline at 4:30 PM Eastern Time on Wednesday, July 11, 2007.

To listen to the audio web cast of the presentation during or after the event, please visit: http://www.auxilium.com. The replay will be available for 90 days after the event.

About Auxilium

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical development. AA4500, an injectable collagenase enzyme, is in phase III of development for the treatment of Dupuytren's contracture and is in phase II of development for the treatment of Peyronie's disease and Frozen Shoulder syndrome (Adhesive Capsulitis). Auxilium's transmucosal film product candidate for the treatment of overactive bladder (AA4010) is in phase I of development. The Company is currently seeking a partner to further develop this product candidate. Auxilium has two pain products using its transmucosal film delivery system in pre-clinical development. Auxilium has rights to six additional pain products and products for hormone replacement and urologic disease using its transmucosal film delivery system, and options to all indications using AA4500 for non-topical formulations. For additional info
'"/>




Page: 1 2 3

Related medicine technology :

1. Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:7/29/2014)... -- Cynosure, Inc. (Nasdaq: CYNO ... treatment systems for high-volume applications, today reported financial results ... 2014 financial results incorporate the acquisition of Palomar Medical ... Second-Quarter 2014 Financial Highlights ... , Non-GAAP net income of $7.1 million, or ...
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)... , July 29, 2014  Drug development for ... rising incidence rates and the intense need for ... vaccine. Change is underway as the market moves ... highly effective, easily-tolerated, interferon-free oral therapies. ... Gilead,s mega blockbuster Sovaldi is the first ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of 16,300,000 shares of ... per share to the public. The gross proceeds to ... $130,400,000, before deducting underwriting discounts and commissions, and other ...
... 26, 2011 American Scientific Resources, Inc. (OTCQB: ASFX) ... and Sanomedics International Holdings, Inc., and its affiliates, have ... United States District Court for the Southern District of ... judge, Hon. Ursula Ungaro, and the case has been ...
Cached Medicine Technology:Rigel Announces Pricing of Public Offering of Common Stock 2Rigel Announces Pricing of Public Offering of Common Stock 3American Scientific Resources, Inc. Announces Dismissal of Sanomedics International Holdings, Inc. lawsuit 2
(Date:7/30/2014)... 30, 2014 Pain Free Living web: ... bracelet for pain relief and improved performance. This new ... embedded in a silicone core that is sheathed in ... and is embedded with scalar energy and Schumann frequency ... Free Living has 12 years experience developing magnetic bracelets. ...
(Date:7/29/2014)... 30, 2014 Recently, iFitDress.com, a well-known wedding ... satin bridal gowns . Aside from this, it has ... up to 68 percent off. All of its old and ... The company’s sales representative says excitedly, “We are pleased to ... new range, there are a lot of amazing items. It ...
(Date:7/29/2014)... 30, 2014 VogueQueen.com, a well-known online ... the newest trends in garment fashion by providing graceful ... is selling an all-inclusive array of sexy dresses ... online, a lot of customers take price into consideration. ... That makes the purchase more affordable for all clients. ...
(Date:7/29/2014)... diet rich in soy may help feminine hearts, but ... in Menopause , the journal of The North ... the diet of women in Asia, produces the least ... to Asian migrants to North America, leads to just ... switching to soy from a Western diet after menopause ...
(Date:7/29/2014)... Daily Gossip indicates in its Natural Cure for Yeast Infection ... who is looking for an all-natural holistic cure for this ... Sarah Summer, says that her method is 100 percent natural. ... this is the reason why she was so determined in ... Natural Cure for Yeast Infection review indicates that Sarah ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:VogueQueen.com Now Provides Graceful And Sexy Lingerie Collection For August 2Health News:Soy may help women's hearts if they start early 2Health News:Natural Cure for Yeast Infection Review Reveals Sarah Summer’s Healing Method 2
... , VIRGINIA BEACH, Va., Jan. 11, 2010 Amerigroup ... report its earnings for the fourth quarter and the fiscal year ... Friday, February 19, 2010. At 8:30 a.m. Eastern Time on ... webcast to discuss earnings and other information. , To listen to ...
... , KNOXVILLE, Tenn., Jan. 11 TeamHealth ... that the underwriters of its recent initial public offering of ... an additional 1,995,000 shares of common stock from the Company ... intends to use the additional net proceeds of approximately $22.5 ...
... Jan. 11 The California Dental Association (CDA) ... charitable Dental Student Loan Repayment Grant Program. Two California ... each receive a maximum of $105,000 to help offset ... commitment to work in an underserved community. , ...
... to be part of the ,culture, at some centers, one ... Americans in nursing homes still get powerful antipsychotic medications, despite ... practice, two new studies show. , The practice can control ... U.S. Food and Drug Administration instituted a "black box" warning ...
... ... Corpus Christi and Austin, Texas areas. , ... San Antonio, TX (PRWEB) January 11, 2010 -- Physicians Health ... choices and benefits than original Medicare -- is pleased to announce it is partnering ...
... , SC AG McMaster to ... , WASHINGTON, Jan. 11 South Carolina Attorney ... general into the constitutionality of the health care reform bill ... press conference at 2:00 p.m. on Wednesday, January 13th, ...
Cached Medicine News:Health News:Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19 2Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 2Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 3Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 4Health News:California Dental Association Foundation Awards More Than $200,000 in Community Service Grants 2Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 2Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 3Health News:Top-Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 2Health News:Top-Rated Medicare Plan Now Offers Silver Life Fitness Program Free to its Members 3
... The new Guidant VASOVIEW® HemoPro™ ... deliver a new level of ... for both the saphenous vein ... cut-and-seal capability, it lets you ...
Patient Monitor...
...
... or antepartum GBS results can be available in ... revolutionary in vitro diagnostic test is the first ... in the clinical lab and near-patient by non-laboratory ... 24 hours a day, 365 days a year. ...
Medicine Products: